Center-Authored Papers

Filters: Author is Gale, R P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bachanova V, Burns LJ, Wang T, Carreras J, Gale RP, Wiernik PH, Ballen KK, Wirk B, Munker R, Rizzieri DA et al..  2015.  Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.. Bone marrow transplantation. 50(2):197-203. Abstract
C
Chen Y-B, Wang T, Hemmer MT, Brady C, Couriel DR, Alousi A, Pidala J, Urbano-Ispizua A, Choi SW, Nishihori T et al..  2016.  GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.. Bone marrow transplantation. Abstract
E
Estey E, Othus M, Lee SJ, Appelbaum FR, Gale RP.  2015.  New drug approvals in acute myeloid leukemia: what's the best end point? Leukemia.
Estey E, Gale RP.  2017.  How good are we at predicting the fate of someone with acute myeloid leukaemia? Leukemia.
Estey E, Gale RP.  2016.  Acute myeloid leukemia therapy and the chosen people.. Leukemia.
G
Godwin CD, Gale RP, Walter RB.  2017.  Gemtuzumab ozogamicin in acute myeloid leukemia.. Leukemia. Abstract
H
Hale GA, Arora M, Ahn KW, He W, Camitta B, Bishop MR, Bitan M, Cairo MS, Chan K, Childs RW et al..  2013.  Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.. Bone marrow transplantation. Abstract
Hourigan CS, Gale RP, Gormley NJ, Ossenkoppele GJ, Walter RB.  2017.  Measurable residual disease testing in acute myeloid leukaemia.. Leukemia. Abstract
K
Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A et al..  2012.  Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.. Bone marrow transplantation. 47(6):810-816. Abstract
L
Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D, Gale RP, Rowlings PA et al..  2014.  Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.. Bone marrow transplantation. Abstract
M
Mahindra A, Kalaycio ME, Vela-Ojeda J, Vesole DH, Zhang M-J, Li P, Berenson JR, Bird JM, Dispenzieri A, Gajewski JL et al..  2012.  Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 26(5):1091-7. Abstract
Malogolowkin MH, Hemmer MT, Le-Rademacher J, Hale GA, Metha PA, Smith AR, Kitko C, Abraham A, Abdel-Azim H, Dandoy C et al..  2017.  Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: a CIBMTR retrospective analysis.. Bone marrow transplantation. Abstract
R
Ringdén O, Shrestha S, da Silva GT, Zhang M-J, Dispenzieri A, Remberger M, Kamble R, Freytes CO, Gale RP, Gibson J et al..  2012.  Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma.. Bone marrow transplantation. 47(6):831-7. Abstract
S
Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C et al..  2015.  A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.. Bone marrow transplantation. 50(11):1416-1423. Abstract
U
Uy GL, Costa LJ, Hari PN, Zhang M-J, Huang J-X, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MAD et al..  2015.  Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.. Bone marrow transplantation. 50(12):1513-8. Abstract